Comparison of the Effects of QLB 2 and QLB 3 on Post-operative Analgesia in Cesarean Section Surgery
CompletedNot applicableNCT04364906
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study evaluates the post-operative analgesic effects of quadratus lomborum block 2 and 3 (QLB 2, 3) in patients having cesarean section with spinal anesthesia. Spinal anesthesia will be performed to all patients for the surgery.
Study details
- Official title
- Comparison of the Effects of Quadratus Lumborum Block 2 and 3 (QLB 2 and QLB 3) on Post-operative Analgesia in Cesarean Section Surgery
- Conditions
- Interventions
- Other: Regional anesthesia
- Sponsor
- Ondokuz Mayıs University
- Start date
- 2020-04-29
- Primary completion
- 2020-09-15
- Sex
- Female
- Age range
- from 18 Years to 45 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Being pregnant for at least 37 weeks * Planning an elective cesarean operation * Being between the ages of 18-45 Exclusion Criteria: * ASA 3-4 patients with comorbitidies (Serious renal, cardiac, hepatic disease) * Being operated with general anesthesia * Obesity (\> 100 kg, BMI\> 35 kg / m2) * Contraindication of regional anesthesia (quagulopathy, abnormal INR, thrombocytopenia, infection at the injection site) * Hypersensitivity to local anesthetics or a history of allergy * Patients with a history of opioid use longer than four weeks * Patients with psychiatric disorders * Patients with anatomic deformity * Patients who do not want to participate
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04364906